Troels Kasper Høyer Scheel

Title: Troels Kasper Høyer Scheel: Innovator in Hepatitis C Research

Introduction

Troels Kasper Høyer Scheel is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of hepatitis C virus (HCV) research, holding a total of six patents. His work focuses on developing innovative cell culture systems and nucleic acid sequences that advance the understanding and treatment of HCV.

Latest Patents

Among his latest patents is the invention of JFH-1 based HCV cell culture systems for NS5A of genotypes 1-7. This invention involves the development of hepatitis C virus recombinants that express NS5A from various genotypes within a genotype 2a backbone. The research revealed adaptive mutations in NS5A and/or NS3 that enhance growth kinetics, as demonstrated in reverse genetic studies. Another notable patent is related to full-length infectious cell culture systems and applications thereof. This invention encompasses nucleic acid sequences encoding HCVs that are essential for fundamental research and vaccine development against HCV.

Career Highlights

Troels has worked at notable institutions such as Hvidovre Hospital and Københavns Universitet. His career is marked by a commitment to advancing medical research and improving therapeutic strategies for hepatitis C.

Collaborations

He has collaborated with esteemed colleagues, including Judith Margarete Gottwein and Jens Bukh, contributing to the collective effort in HCV research.

Conclusion

Troels Kasper Høyer Scheel's innovative work in hepatitis C research has led to significant advancements in understanding the virus and developing potential treatments. His contributions continue to impact the field positively.